International high-risk clones of Klebsiella pneumoniae KPC-2/CC258 and Escherichia coli CTX-M-15/CC10 in urban lake waters

Carregando...
Imagem de Miniatura
Citações na Scopus
50
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
NASCIMENTO, Tatiane
CANTAMESSA, Rodrigo
MELO, Luana
FERNANDES, Miriam R.
DROPA, Milena
SATO, Maria I. Z.
CERDEIRA, Louise
LINCOPAN, Nilton
Citação
SCIENCE OF THE TOTAL ENVIRONMENT, v.598, p.910-915, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The emergence of high-risk clones of multidrug-resistant (MDR) bacteria in aquatic environments has generated an important public health problem, creating an urgent need to strengthen surveillance. This study reports the occurrence of clinically significant MDR Enterobacteriaceae and non-fermentative bacteria carrying carbapenemases (KPC-2), extended-spectrum beta-lactamases (CTX-M) and plasmid-mediated quinolone resistance (PMQR) genes in urban lakes and reservoirs, in Southeastern Brazil. In this regard, the detection of hospital-associated lineages of KPC-2-producing Klebsiella pneumoniae belonging to the international clonal complex CC258 (STH) and CTX-M-15-producing Escherichia coli belonging to the international CC10 (ST617), in an urban lake, is reported for the first time. Whole genome sequencing (WGS) analysis of KPC-2-producing K. pneumoniae ST11 revealed that bla(KPC-2) gene was carried by an IncN plasmid on a Tn4401b element. This study support that aquatic environments with public access can act as reservoirs of clinically important MDR bacteria, constituting a potential risk to human and animal health. On the other hand, the detection of high-risk clones highlights the extra-hospital spread of clinically significant bacteria into urban aquatic environments.
Palavras-chave
Enterobacteriaceae, K pneumoniae ST11, E. coli ST617, CTX-M, PMQR, Aquatic environment
Referências
  1. Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x
  2. Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264
  3. [Anonymous], 2012, STANDARD METHODS EXA
  4. Andrade LN, 2014, J CLIN MICROBIOL, V52, P2530, DOI 10.1128/JCM.00088-14
  5. Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10
  6. Aydin F, 2007, J APPL MICROBIOL, V103, P27, DOI 10.1111/j.1365-2672.2006.03240.x
  7. Baez J, 2015, MICROB DRUG RESIST, V21, P111, DOI 10.1089/mdr.2014.0158
  8. Bajaj P, 2015, SCI TOTAL ENVIRON, V505, P350, DOI 10.1016/j.scitotenv.2014.09.084
  9. Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042
  10. Ben Sallem R, 2015, J CHEMOTHERAPY, V27, P114, DOI 10.1179/1973947814Y.0000000172
  11. Berglund Bjorn, 2015, Infection Ecology & Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564
  12. Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413
  13. Campana EH, 2017, INT J ANTIMICROB AG, V49, P119, DOI 10.1016/j.ijantimicag.2016.10.006
  14. Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000
  15. Clinical and Laboratory Standards Institute (CLSI), 2013, VET01A4 CLSI
  16. CLSI (Clinical Laboratory Standards Institute), 2015, M100S25 CLSI
  17. Conte D, 2017, ECOTOX ENVIRON SAFE, V136, P62, DOI 10.1016/j.ecoenv.2016.10.031
  18. Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291
  19. Dropa M, 2016, ENVIRON SCI POLLUT R, V23, P4953, DOI 10.1007/s11356-016-6079-5
  20. European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS
  21. Fang LX, 2016, SCI REP-UK, V6, DOI 10.1038/srep25312
  22. Fernandes MR, 2016, ANTIMICROB AGENTS CH, V60, P6415, DOI 10.1128/AAC.01325-16
  23. Ferreira AE, 2011, MICROB DRUG RESIST, V17, P221, DOI 10.1089/mdr.2010.0013
  24. Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355
  25. Fontes LC, 2011, ANTIMICROB AGENTS CH, V55, P3063, DOI 10.1128/AAC.00138-11
  26. Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246
  27. Ho PL, 2013, J MED MICROBIOL, V62, P1707, DOI 10.1099/jmm.0.062653-0
  28. Leclercq R, 2013, CLIN MICROBIOL INFEC, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x
  29. Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895
  30. Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7
  31. de Araujo CFM, 2016, ANTIMICROB AGENTS CH, V60, P4380, DOI 10.1128/AAC.02753-15
  32. Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
  33. Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11
  34. Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14
  35. Sampaio JLM, 2016, BRAZ J MICROBIOL, V47, P31, DOI 10.1016/j.bjm.2016.10.002
  36. Monte D. F., 2017, ANTIMICROB AGENTS CH
  37. Montezzi LF, 2015, INT J ANTIMICROB AG, V45, P174, DOI 10.1016/j.ijantimicag.2014.10.016
  38. Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x
  39. Novais A, 2012, ANTIMICROB AGENTS CH, V56, P2763, DOI 10.1128/AAC.06001-11
  40. Oliveira S, 2014, J ANTIMICROB CHEMOTH, V69, P849, DOI 10.1093/jac/dkt431
  41. Oteo J, 2016, J ANTIMICROB CHEMOTH, V71, P3392, DOI 10.1093/jac/dkw321
  42. Pereira PS, 2013, J ANTIMICROB CHEMOTH, V68, P312, DOI 10.1093/jac/dks396
  43. Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001
  44. Pitondo-Silva A, 2009, CAN J MICROBIOL, V55, P672, DOI [10.1139/w09-019, 10.1139/W09-019]
  45. Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431
  46. Roca I., 2015, NEW MICROBES NEW INF, V16, P22
  47. Rocha-Gracia RC, 2015, VET J, V203, P315, DOI 10.1016/j.tvjl.2014.12.026
  48. Rodrigues VFV, 2016, MAR POLLUT BULL, V109, P163, DOI 10.1016/j.marpolbul.2016.06.007
  49. Schwaiger K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00088
  50. Sellera FP, 2017, J ANTIMICROB CHEMOTH, V72, P1255, DOI 10.1093/jac/dkw543
  51. Seni Jeremiah, 2016, Front Microbiol, V7, P142, DOI 10.3389/fmicb.2016.00142
  52. Smet A, 2010, MICROB DRUG RESIST, V16, P129, DOI 10.1089/mdr.2009.0132
  53. Tacao M, 2014, WATER RES, V48, P100, DOI 10.1016/j.watres.2013.09.021
  54. Takahashi Juliana Possato, 2012, Hoehnea, V39, P287, DOI 10.1590/S2236-89062012000200008
  55. Tryjanowski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063482
  56. Turano H, 2016, DIAGN MICR INFEC DIS, V86, P80, DOI 10.1016/j.diagmicrobio.2016.06.005
  57. Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392
  58. Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x
  59. Yang FX, 2017, SCI TOTAL ENVIRON, V581, P136, DOI [10.1016/j.scitotenv.2016.12.063, 10.1016/jscitotenv2016.12.063]